# Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

> **NCT01109407** · — · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 225 (actual)

## Conditions studied

- Smoldering Myeloma
- Monoclonal Gammopathy of Undetermined Significance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01109407
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04-22
- **Primary completion:** 2014-05-16
- **Final completion:** 2021-02-25
- **Target enrollment:** 225 (ACTUAL)
- **Why stopped:** PI Left before primary outcome was established
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109407, "Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01109407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*